vs
ExlService Holdings, Inc.（EXLS）与森馨科技（SXT）财务数据对比。点击上方公司名可切换其他公司
ExlService Holdings, Inc.的季度营收约是森馨科技的1.2倍（$542.6M vs $435.8M），ExlService Holdings, Inc.净利率更高（11.1% vs 10.1%，领先1.0%），森馨科技同比增速更快（54.2% vs 12.7%），过去两年ExlService Holdings, Inc.的营收复合增速更高（11.5% vs 3.9%）
ExlService Holdings Inc.是全球知名的分析与数字解决方案服务商，服务覆盖保险、医疗健康、银行金融服务、媒体、零售等多个行业，总部位于纽约，在美国、欧洲、亚洲、拉美、澳大利亚、南非等地拥有超过5.4万名专业从业人员。
森馨科技是总部位于美国威斯康星州密尔沃基的全球化色素、香精香料生产商及销售商，产品广泛应用于食品饮料、医药、化妆品、家居个护、特种印刷成像、计算机成像及工业着色等多个领域，旗下设有香精香料事业部与色素事业部两大核心业务板块。
EXLS vs SXT — 直观对比
营收规模更大
EXLS
是对方的1.2倍
$435.8M
营收增速更快
SXT
高出41.5%
12.7%
净利率更高
EXLS
高出1.0%
10.1%
两年增速更快
EXLS
近两年复合增速
3.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $542.6M | $435.8M |
| 净利润 | $60.2M | $44.2M |
| 毛利率 | 38.6% | — |
| 营业利润率 | 14.4% | 15.3% |
| 净利率 | 11.1% | 10.1% |
| 营收同比 | 12.7% | 54.2% |
| 净利润同比 | 18.9% | 28.2% |
| 每股收益（稀释后） | $0.38 | $1.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXLSSXT
| Q1 26 | — | $435.8M | ||
| Q4 25 | $542.6M | $393.4M | ||
| Q3 25 | $529.6M | $412.1M | ||
| Q2 25 | $514.5M | $414.2M | ||
| Q1 25 | $501.0M | $392.3M | ||
| Q4 24 | $481.4M | $376.4M | ||
| Q3 24 | $472.1M | $392.6M | ||
| Q2 24 | $448.4M | $403.5M |
净利润EXLSSXT
| Q1 26 | — | $44.2M | ||
| Q4 25 | $60.2M | $25.5M | ||
| Q3 25 | $58.2M | $37.0M | ||
| Q2 25 | $66.1M | $37.6M | ||
| Q1 25 | $66.6M | $34.5M | ||
| Q4 24 | $50.7M | $30.1M | ||
| Q3 24 | $53.0M | $32.7M | ||
| Q2 24 | $45.8M | $30.9M |
毛利率EXLSSXT
| Q1 26 | — | — | ||
| Q4 25 | 38.6% | 31.4% | ||
| Q3 25 | 38.5% | 34.3% | ||
| Q2 25 | 37.7% | 34.5% | ||
| Q1 25 | 38.6% | 33.6% | ||
| Q4 24 | 38.1% | 31.7% | ||
| Q3 24 | 37.8% | 33.2% | ||
| Q2 24 | 37.1% | 32.4% |
营业利润率EXLSSXT
| Q1 26 | — | 15.3% | ||
| Q4 25 | 14.4% | 9.7% | ||
| Q3 25 | 14.4% | 14.0% | ||
| Q2 25 | 15.8% | 13.9% | ||
| Q1 25 | 15.7% | 13.6% | ||
| Q4 24 | 14.8% | 11.2% | ||
| Q3 24 | 14.7% | 12.9% | ||
| Q2 24 | 13.7% | 12.3% |
净利率EXLSSXT
| Q1 26 | — | 10.1% | ||
| Q4 25 | 11.1% | 6.5% | ||
| Q3 25 | 11.0% | 9.0% | ||
| Q2 25 | 12.8% | 9.1% | ||
| Q1 25 | 13.3% | 8.8% | ||
| Q4 24 | 10.5% | 8.0% | ||
| Q3 24 | 11.2% | 8.3% | ||
| Q2 24 | 10.2% | 7.7% |
每股收益（稀释后）EXLSSXT
| Q1 26 | — | $1.04 | ||
| Q4 25 | $0.38 | $0.60 | ||
| Q3 25 | $0.36 | $0.87 | ||
| Q2 25 | $0.40 | $0.88 | ||
| Q1 25 | $0.40 | $0.81 | ||
| Q4 24 | $0.31 | $0.71 | ||
| Q3 24 | $0.33 | $0.77 | ||
| Q2 24 | $0.28 | $0.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $328.4M | $38.5M |
| 总债务越低越好 | $298.6M | $767.8M |
| 股东权益账面价值 | $912.7M | $1.2B |
| 总资产 | $1.7B | $2.3B |
| 负债/权益比越低杠杆越低 | 0.33× | 0.63× |
8季度趋势，按日历期对齐
现金及短期投资EXLSSXT
| Q1 26 | — | $38.5M | ||
| Q4 25 | $328.4M | $36.5M | ||
| Q3 25 | $390.1M | $42.7M | ||
| Q2 25 | $353.3M | $56.7M | ||
| Q1 25 | $331.4M | $32.6M | ||
| Q4 24 | $340.6M | $26.6M | ||
| Q3 24 | $325.8M | $37.0M | ||
| Q2 24 | $276.1M | $30.3M |
总债务EXLSSXT
| Q1 26 | — | $767.8M | ||
| Q4 25 | $298.6M | $709.2M | ||
| Q3 25 | $354.8M | — | ||
| Q2 25 | $260.0M | — | ||
| Q1 25 | $307.3M | — | ||
| Q4 24 | $288.5M | $613.5M | ||
| Q3 24 | $344.7M | — | ||
| Q2 24 | — | — |
股东权益EXLSSXT
| Q1 26 | — | $1.2B | ||
| Q4 25 | $912.7M | $1.2B | ||
| Q3 25 | $952.4M | $1.2B | ||
| Q2 25 | $1.1B | $1.2B | ||
| Q1 25 | $1.0B | $1.1B | ||
| Q4 24 | $929.9M | $1.1B | ||
| Q3 24 | $907.6M | $1.1B | ||
| Q2 24 | $852.6M | $1.1B |
总资产EXLSSXT
| Q1 26 | — | $2.3B | ||
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.7B | $2.2B | ||
| Q2 25 | $1.7B | $2.2B | ||
| Q1 25 | $1.7B | $2.1B | ||
| Q4 24 | $1.6B | $2.0B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.5B | $2.0B |
负债/权益比EXLSSXT
| Q1 26 | — | 0.63× | ||
| Q4 25 | 0.33× | 0.59× | ||
| Q3 25 | 0.37× | — | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | 0.31× | 0.58× | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $117.4M | — |
| 自由现金流经营现金流 - 资本支出 | $106.5M | — |
| 自由现金流率自由现金流/营收 | 19.6% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | 1.95× | — |
| 过去12个月自由现金流最近4个季度 | $298.1M | — |
8季度趋势，按日历期对齐
经营现金流EXLSSXT
| Q1 26 | — | — | ||
| Q4 25 | $117.4M | $44.6M | ||
| Q3 25 | $120.7M | $44.0M | ||
| Q2 25 | $109.4M | $48.3M | ||
| Q1 25 | $3.2M | $-9.0M | ||
| Q4 24 | $105.3M | $21.4M | ||
| Q3 24 | $110.1M | $76.8M | ||
| Q2 24 | $74.9M | $43.8M |
自由现金流EXLSSXT
| Q1 26 | — | — | ||
| Q4 25 | $106.5M | $12.9M | ||
| Q3 25 | $106.4M | $24.2M | ||
| Q2 25 | $95.0M | $27.1M | ||
| Q1 25 | $-9.7M | $-25.8M | ||
| Q4 24 | $95.3M | $-1.7M | ||
| Q3 24 | $97.3M | $63.6M | ||
| Q2 24 | $62.8M | $32.0M |
自由现金流率EXLSSXT
| Q1 26 | — | — | ||
| Q4 25 | 19.6% | 3.3% | ||
| Q3 25 | 20.1% | 5.9% | ||
| Q2 25 | 18.5% | 6.5% | ||
| Q1 25 | -1.9% | -6.6% | ||
| Q4 24 | 19.8% | -0.5% | ||
| Q3 24 | 20.6% | 16.2% | ||
| Q2 24 | 14.0% | 7.9% |
资本支出强度EXLSSXT
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 8.0% | ||
| Q3 25 | 2.7% | 4.8% | ||
| Q2 25 | 2.8% | 5.1% | ||
| Q1 25 | 2.6% | 4.3% | ||
| Q4 24 | 2.1% | 6.1% | ||
| Q3 24 | 2.7% | 3.4% | ||
| Q2 24 | 2.7% | 2.9% |
现金转化率EXLSSXT
| Q1 26 | — | — | ||
| Q4 25 | 1.95× | 1.75× | ||
| Q3 25 | 2.08× | 1.19× | ||
| Q2 25 | 1.66× | 1.28× | ||
| Q1 25 | 0.05× | -0.26× | ||
| Q4 24 | 2.08× | 0.71× | ||
| Q3 24 | 2.08× | 2.35× | ||
| Q2 24 | 1.63× | 1.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
SXT
暂无分部数据
